Itovebi 3 mg

Itovebi 3 mg is a medicine authorised by Swissmedic under authorisation number 69792. The authorisation holder is Roche Pharma (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 31 January 2025 and the authorisation is limited until 30 January 2030. ATC code L01EM06 places the medicine in the group Antineoplastic agents.

Dispensing category A
Authorisation number 69792
ATC L01EM06
Synthetic medicines

Authorisation data
Authorisation number	69792
Name	Itovebi 3 mg
Full name	Itovebi 3 mg, Filmtabletten
Authorisation holder	Roche Pharma (Schweiz) AG
Medicinal product code	Synthetic medicines
Dispensing category	A · Prescription, not repeatable
ATC code	L01EM06
First authorisation	31 January 2025
Authorisation validity	30 January 2030

Strengths
No.	Name	Dispensing category	Authorisation date
1	Itovebi 3 mg, Filmtabletten	A	31 January 2025
2	Itovebi 9 mg, Filmtabletten	A	31 January 2025

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
1	28	Tablette(n)	L01EM06	07.16.1.	A
2	28	Tablette(n)	L01EM06	07.16.1.	A

Scroll the table sideways

Other medicines from this authorisation holder

Actemra 162 mg/0.9 mlAuthorisation number 63166 · ATC L04AC07A Actemra 162 mg/0.9 mlAuthorisation number 66931 · ATC L04AC07A Actemra 80 mg/4 mlAuthorisation number 58868 · ATC L04AC07A Alecensa 150 mgAuthorisation number 65970 · ATC L01ED03A Avastin 100 mg/4 mlAuthorisation number 56922 · ATC L01FG01A CellceptAuthorisation number 54701 · ATC L04AA06B Cellcept 250 mgAuthorisation number 53337 · ATC L04AA06B Cellcept 500 mgAuthorisation number 53338 · ATC L04AA06B

Frequently asked questions

Is Itovebi 3 mg authorised in Switzerland?

Yes. Itovebi 3 mg is authorised by Swissmedic under authorisation number 69792, data as of 01 September 2026. The authorisation is limited until 30 January 2030.

Which dispensing category does Itovebi 3 mg have?

Itovebi 3 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Itovebi 3 mg?

The authorisation holder is Roche Pharma (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.